Navigation Links
RTA 402 Shown to Inhibit STAT3 in Animal Model and Holds,Significant Promise for Treating Breast Cancer

growth, invasion, and metastasis. It has also been shown to have a role in preventing the patient's immune system from recognizing and destroying the tumor. It is thought that cancer therapies able to inhibit STAT3 may have profound anti-cancer effects, which may include re-establishing normal immune function against the tumor. The 4T1 animal studies, which are performed in mice that have a normal immune system, provide support for this idea. When researchers examined the spleens of tumor-bearing animals, they found that untreated control animals had a significant reduction in the number of immune cells in their spleens. Animals receiving RTA 402, however, had levels of immune cells that were consistent with healthy, cancer-free animals.

"This paper provides important new data on how RTA 402 works to inhibit the growth and metastasis of cancer," said Warren Huff, CEO of Reata. "The effects on STAT3 shown in this paper, combined with the drugs' proven inhibition of NF-kB, indicate that these agents modulate important and inter-related pathways in cancer cells."

About Reata

Reata Pharmaceuticals, Inc. is a biopharmaceutical company focused on selecting and discovering promising early drug development opportunities and translating them into successful marketed drugs that target major unmet clinical needs in cancer, inflammation and neurodegenerative disease. The company's two lead programs are entering advanced clinical trials for deadly, late-stage cancers. In parallel with its clinical development, Reata is advancing a breakthrough drug discovery platform that addresses protein misfolding, a key factor in cancer and neurodegenerative disease, to feed its pipeline of small molecule therapeutic candidates. Reata takes a new and different approach to biotechnology, managing its pipeline as a portfolio of opportunities that can be advanced on a single management and physical infrastructure, streamlining the route to human trials and approval. Founded
'"/>




Page: 1 2 3

Related medicine technology :

1. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
2. Gabapentin Shown Effective for Fibromyalgia Pain
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
4. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
5. Efficacy and Safety Profile of Basileas Alitretinoin for Severe Refractory Chronic Hand Eczema Confirmed by Data Shown at European Dermatology Congress
6. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
7. Accelreon Pharmas ACE-031Shown to Increase Muscle Mass in Preclinical Studies
8. Cethromycin Shown Effective Against Anthrax in Study
9. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme

Post Your Comments:
(Date:12/1/2009)..., , WHITEHOUSE STATION, N.J., Dec. 1 /PRN...that the U.S. Food and Drug Administration (FDA) h...um bicarbonate 1100 mg capsules), for over-the-cou... will be marketed over-the-counter by Schering-Plo...care division of Merck & Co., Inc. Schering-Pl...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 ...rch report is available in its catalogue: ,, T...sts to 2015, Competitive Benchmarking, Product Pip...linker.com/p0166817/The-Future-of-Oncology-Therape...marking-Product-Pipeline-and-Deals-Analysis.html ...
(Date:12/1/2009)..., , NEWNAN, Ga., Dec. 1 /PRNewswire/...ialty surface treatments for medical devices and o...nt and Chief Executive Officer, Thomas A. Gordy, w...ade at the Innovations in Cardiovascular Intervent...ve the era of petty self-interest behind and focus...
Breaking Medicine Technology:FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 2FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 3FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn 4Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Reportlinker Adds The Future of Oncology Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices 2Dr Susan Blumenthal Meridian International Centers Global Health Chair Named Health Leader of the Year 49759 1Dr Susan Blumenthal Meridian International Centers Global Health Chair Named Health Leader of the Year 49759 2Dr Susan Blumenthal Meridian International Centers Global Health Chair Named Health Leader of the Year 49759 3Marking anorexia with a brain protein 49756 1Medical Study Establishes First Ever Long Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement 49755 1
...ta on Newly-Approved Cimzia(R) Presented at Digest...nounced today that data,presented at Digestive Dis...cacy and safety of Cimzia(R) (certolizumab pegol) ... to severe Crohn,s disease. Data also showed,conti...and the remission,rate remained stable in many of ...
... Clinical trial data for Perforomist(TM) (Formoter... at International ATS Conference --, NAPA, Calif....l Conference of the American Thoracic Society (ATS...omist(TM) Inhalation Solution,(formoterol fumarate...tion,and Spiriva(R) (tiotropium; TIO) is significa...
Other Medicine Technology:Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 2Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 3Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 4Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 5Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 6Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 7Cimzia(R) Provides Long-Term Efficacy with Stable Dosing in Crohn's Disease 8Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 2Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 3Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 4Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 5Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone 6
(Date:12/1/2009)..., Dec. 1 Reportlinker.com announce...n its catalogue: ,, Peptic Ulcer Testing - A W....reportlinker.com/p0164350/Peptic-Ulcer-Testing---...he prevalence of peptic ulcers in developing, and ...ped countries. The bacteria, helicobacter pylori (...
(Date:12/1/2009)...preterm births more likely, British study finds ,...egnant women who are poor are more likely to deliv...ven though both groups typically receive equal car...of Leicester research team said their findings sho...ween economic status and preterm birth. , For t...
(Date:12/1/2009)...S, Dec. 1 The American ...igh School Student Symposium at the New Orleans Ma...The symposium, which encourages an interest in hem...arch, is held in conjunction with the Society,s 51...he opportunity to explore research on sickle cell ...
(Date:12/1/2009)..., Dec. 1 On December 31...8 federal prisoners were HIV positive or had confi...in the Office of Justice Programs, U.S. Department...estimated 5,672 inmates in state and federal priso... 2007, about 43 per 10,000 prison inmates were est...
(Date:12/1/2009)...uld benefit from liver surgery after chemo, study ...ews) -- A CT scan of liver tumors caused by the sp... survival after chemotherapy, researchers report. ...motherapy has been shown to improve survival in pa...oduce better results in patients having surgery to...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Peptic Ulcer Testing - A World Market Intelligence Report 2Health News:Reportlinker Adds Peptic Ulcer Testing - A World Market Intelligence Report 3Health News:More Preemies Born Among the Poor 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 2Health News:Rate of Confirmed AIDS in Prison 2.5 Times the Rate in the U.S. General Population 3Health News:CT Scan May Predict Colon Cancer Survival 2
...ugh what was once,Hurricane Gustav has weakened to...es all evacuees to stay away from affected areas u...w people are eager to go home, especially if they ...re,still unsafe in many places." If authorities ha...
...tion and Entertainment to State,s Largest Hospice ...LS, S.D., Sept. 2 LodgeNet,Healthcare, a division...T ),today announced that it has expanded into Hawa...ncis Hospice,established in 1978, is the oldest an...
...ver, Madonna," read a recent,San Francisco Chronic...t -,Music for the Soul debuted at #9 on the Billbo... of Pop and above Grammy Best New Artist of the,Ye...s #1 on the Billboard Classical Chart in the US, a...
...ce to prescribe antidepressants, study suggests , ...cides among U.S. children appear to be on the rise...n part, to fewer teens being prescribed antidepres... suicides continued during 2005. , Looking at suic...
...th University Massey Cancer Center recently opened...e II clinical study for certain sub-types of non-H...rch from VCU Massey Cancer Center as well as other... with diffuse large B-cell lymphoma, or mantle cel...
...olina at Chapel Hill researchers have demonstrated...ing, the need for intravenous fluids and hospital ... , Gastroenteritis is an infection, often caused ...onths. , "Children under the age of 5 years gener...
Other Medicine News:Health News:Red Cross Advises Evacuees to Stay Put Until Conditions Are Safe 2Health News:LodgeNet Healthcare Expands Into Hawaii Through Agreement With St. Francis Hospice 2Health News:LodgeNet Healthcare Expands Into Hawaii Through Agreement With St. Francis Hospice 3Health News:Youth Suicides Continue to Rise in U.S. 2Health News:Youth Suicides Continue to Rise in U.S. 3Health News:VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients 2Health News:Ondansetron reduces vomiting, hospital admissions in children with gastroenteritis 2
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products: